Religious leaders are strongly resisting Covid restrictions, Hong Kong and Singapore are scheduled to test the world's first comprehensive quarantine free air-travel bubble on November 22, and more
While Maharashtra adds over 5,000 cases three days in a row, the total cases in the US cross the 12 million mark
India's Covid-19 caseload rose to 9.05 mn, while the number of people who have recuperated from the disease surged to over 8.4 mn pushing the national recovery rate to 93.67%
Ten months into the pandemic, what have we learned and what other measures do we have in our collective toolkit?
Correa is executive director, South Centre, an inter-governmental organisation which works on various issues affecting developing countries such as climate change, food security, etc
The overall number of global coronavirus cases has surpassed the 57 million mark, while the deaths have surged to more than 1.36 million, according to the Johns Hopkins University.
Pfizer asked US regulators to allow emergency use of its COVID vaccine, starting clock on a process that could bring limited first shots as early as next month and eventually an end to the pandemic
NEW YORK (Reuters) - The S&P 500 and the Dow edged lower on Friday as investors headed into the weekend grappling with disappointing fiscal stimulus news and uncertain efforts to combat a spiraling COVID-19 pandemic with vaccines.
The action comes days after Pfizer Inc and its German partner BioNTech announced that its vaccine appears 95% effective at preventing Covid-19
At a meeting of the finance ministers of G-20, she said further efforts should be made by members of the grouping to end the Covid-19 crisis.
In September, DRL and RDIF had tied up to conduct clinical trials and distribute the vaccine in India.
He also highlighted India's tryst with the coronavirus pandemic as an evidence of cooperation between the public and private sectors
The night curfew everyday from 9 pm to 6 am to continue thereafter,
Haryana Health Minister Anil Vij was on Friday administered a trial dose of potential coronavirus vaccine Covaxin, becoming the first volunteer in the state for the third phase trial of the vaccine. The third phase trial of Bharat Biotech's Covaxin began in the state on Friday and the 67-year old senior Bharatiya Janata Party leader was administered the trial dose at the Civil Hospital at Ambala Cantt. Covaxin is being developed indigenously by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR). Meanwhile, Union Health and Family Welfare Minister Dr Harsh Vardhan has said he was confident that Covid-19 vaccine would be ready in the next three-four months and added that the priority to provide the same to 1.3 billion Indians would be based on scientific evaluation.
The study, published in the journal Physics of Fluids, determined associations between people's physiological features and how far their sneeze droplets travel and linger in the air
Fitch expects India's reforms to spur growth, US may slap tariffs on India for taxing internet firms like Google, and more top headlines of the day
Coronavirus update: US is the worst-hit country with 12,072,560 coronavirus cases, followed by India, which has 9,004,365 cases, Brazil (5,912,903), France (2,065,138), Russia (1,991,998)
The extraordinary results have sparked euphoria as the unprecedented compression of vaccine development timelines from years to months looks to be paying off
The vaccine developers are slowly, but surely are accepting the reality of not meeting the estimated targets in producing shots
New York City's public school system will be shut and this time it may take months for reopening. Finland's prime minister warns populists will prosper if Covid-19 is not checked